187 related articles for article (PubMed ID: 18373357)
1. Isolation and identification of potential urinary microparticle biomarkers of bladder cancer.
Smalley DM; Sheman NE; Nelson K; Theodorescu D
J Proteome Res; 2008 May; 7(5):2088-96. PubMed ID: 18373357
[TBL] [Abstract][Full Text] [Related]
2. Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
Chen CL; Lai YF; Tang P; Chien KY; Yu JS; Tsai CH; Chen HW; Wu CC; Chung T; Hsu CW; Chen CD; Chang YS; Chang PL; Chen YT
J Proteome Res; 2012 Dec; 11(12):5611-29. PubMed ID: 23082778
[TBL] [Abstract][Full Text] [Related]
3. Proteome analysis of gelatin-bound urinary proteins from patients with bladder cancers.
Saito M; Kimoto M; Araki T; Shimada Y; Fujii R; Oofusa K; Hide M; Usui T; Yoshizato K
Eur Urol; 2005 Nov; 48(5):865-71. PubMed ID: 15964125
[TBL] [Abstract][Full Text] [Related]
4. Stage-dependent increase of orosomucoid and zinc-alpha2-glycoprotein in urinary bladder cancer.
Irmak S; Tilki D; Heukeshoven J; Oliveira-Ferrer L; Friedrich M; Huland H; Ergün S
Proteomics; 2005 Nov; 5(16):4296-304. PubMed ID: 16196100
[TBL] [Abstract][Full Text] [Related]
5. Searching cell-secreted proteomes for potential urinary bladder tumor markers.
Lin CY; Tsui KH; Yu CC; Yeh CW; Chang PL; Yung BY
Proteomics; 2006 Aug; 6(15):4381-9. PubMed ID: 16819731
[TBL] [Abstract][Full Text] [Related]
6. Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry.
Issaq HJ; Nativ O; Waybright T; Luke B; Veenstra TD; Issaq EJ; Kravstov A; Mullerad M
J Urol; 2008 Jun; 179(6):2422-6. PubMed ID: 18433783
[TBL] [Abstract][Full Text] [Related]
7. [Influence of blood cells in urine samples on results of screening for urothelial carcinoma with NMP22 bladder chek].
Ueda Y; Kawaguchi R; Takiuchi H; Kokura K; Yoshimoto T; Mitsui Y; Suzuki T; Jun Q; Higuchi Y; Maruyama T; Kondoh N; Nozima M; Yamamoto S; Shima H
Hinyokika Kiyo; 2009 Feb; 55(2):71-4. PubMed ID: 19301610
[TBL] [Abstract][Full Text] [Related]
8. Urinary nucleosides based potential biomarker selection by support vector machine for bladder cancer recognition.
Mao Y; Zhao X; Wang S; Cheng Y
Anal Chim Acta; 2007 Aug; 598(1):34-40. PubMed ID: 17693304
[TBL] [Abstract][Full Text] [Related]
9. Identification of rat urinary glycoproteome captured by three lectins using gel and LC-based proteomics.
Moon PG; Hwang HH; Boo YC; Kwon J; Cho JY; Baek MC
Electrophoresis; 2008 Nov; 29(21):4324-31. PubMed ID: 18956432
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.
Roblick UJ; Bader FG; Hammarstedt L; Habermann JK; Hellman U; Becker S; Sundmacker A; Gemoll T; Zimmermann K; Auer G; Munck-Wikland E
Acta Oncol; 2008; 47(8):1493-501. PubMed ID: 18759147
[TBL] [Abstract][Full Text] [Related]
11. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N
Urol J; 2009; 6(2):101-8. PubMed ID: 19472128
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor growth and prognosis in patients with bladder cancer: correlation with matrix metalloproteinase-2 and -7 and E-cadherin.
Miyata Y; Sagara Y; Kanda S; Hayashi T; Kanetake H
Hum Pathol; 2009 Apr; 40(4):496-504. PubMed ID: 19121849
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of urine tumor-associated trypsin inhibitor, CYFRA 21-1, and urinary bladder cancer antigen for detection of high-grade bladder carcinoma.
Gkialas I; Papadopoulos G; Iordanidou L; Stathouros G; Tzavara C; Gregorakis A; Lykourinas M
Urology; 2008 Nov; 72(5):1159-63. PubMed ID: 18514770
[TBL] [Abstract][Full Text] [Related]
14. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma.
Paner GP; McKenney JK; Epstein JI; Amin MB
Am J Surg Pathol; 2008 Jul; 32(7):1022-8. PubMed ID: 18469707
[TBL] [Abstract][Full Text] [Related]
15. A panel of angiogenic factors for early bladder cancer detection: enzyme immunoassay and Western blot.
Eissa S; Swellam M; Labib RA; El-Zayat T; El Ahmady O
J Urol; 2009 Mar; 181(3):1353-60. PubMed ID: 19185322
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of phosphopeptides in search of the disease biomarker from the hepatocellular carcinoma specimen.
Lee HJ; Na K; Kwon MS; Kim H; Kim KS; Paik YK
Proteomics; 2009 Jun; 9(12):3395-408. PubMed ID: 19562805
[TBL] [Abstract][Full Text] [Related]
17. Urinary insulin-like growth factor 2 identifies the presence of urothelial carcinoma of the bladder.
Watson JA; Burling K; Fitzpatrick P; Kay E; Kelly J; Fitzpatrick JM; Dervan PA; McCann A
BJU Int; 2009 Mar; 103(5):694-7. PubMed ID: 19040529
[TBL] [Abstract][Full Text] [Related]
18. Proteomics and detection of uromodulin in first-time renal calculi patients and recurrent renal calculi patients.
Wai-Hoe L; Wing-Seng L; Ismail Z; Lay-Harn G
Appl Biochem Biotechnol; 2009 Oct; 159(1):221-32. PubMed ID: 19145410
[TBL] [Abstract][Full Text] [Related]
19. Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C
Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
[TBL] [Abstract][Full Text] [Related]
20. Telomerase and other novel approaches to bladder cancer detection.
Bennett A
Clin Lab Sci; 2008; 21(3):185-90; quiz 191-2, following 192. PubMed ID: 18678141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]